Featured Research

from universities, journals, and other organizations

Study links moderate activity to lower breast cancer risk

Date:
October 4, 2013
Source:
American Cancer Society
Summary:
A large new American Cancer Society study adds to increasing evidence that physical activity reduces the risk of breast cancer in postmenopausal women.

Researchers from the American Cancer Society have found that walking at least 7 hours per week is associated with a 14% lower risk of developing breast cancer after menopause. This finding is consistent with many other studies that show regular exercise can help women lower their risk of breast cancer. New information in this study found the exercise helped women whether or not they were overweight, and helped them even if they gained weight during the study.

It was published early online October 4, 2013 in Cancer Epidemiology, Biomarkers, and Prevention.

The researchers looked at breast cancer status and exercise levels in 73,615 postmenopausal women taking part in the CPS-II Nutritional Cohort, a study begun by the American Cancer Society in 1992. During the 17-year study, 4,760 of the women were diagnosed with breast cancer.

Among the women who reported walking as their only activity, those who walked at least 7 hours per week had a 14% lower risk of breast cancer compared to those who walked 3 or fewer hours per week. The women walked at a "moderate" pace -- about 3 miles per hour. The most active women -- those who walked and did more vigorous exercise -- had a 25% lower risk of breast cancer compared to the least active.

"Our results clearly support an association between physical activity and postmenopausal breast cancer, with more vigorous activity having a stronger effect," said Alpa Patel, PhD, leader of the study and American Cancer Society strategic director of Cancer Prevention Study-3. "Our findings are particularly relevant, as people struggle with conflicting information about how much activity they need to stay healthy. Without any other recreational physical activities, walking on average of at least one hour per day was associated with a modestly lower risk of breast cancer. More strenuous and longer activities lowered the risk even more."

Women in the study benefited from physical activity whether they were at a healthy weight, overweight, or obese, and even if they gained weight during the study. They also benefited whether or not they were taking menopausal hormone therapy. Exercise reduced the risk of both estrogen receptor positive and estrogen receptor negative cancers. (In estrogen receptor-positive breast cancer, the female hormone estrogen promotes the growth of the cancer. Hormone therapy for breast cancer works by blocking the effects of estrogen or lowering estrogen levels. Estrogen receptor-negative breast cancer is often harder to treat because it is not likely to respond to hormone therapy.)

The American Cancer Society recommends that adults get at least 150 minutes of moderate-intensity or 75 minutes of vigorous-intensity activity each week, preferably spread throughout the week. Moderate-intensity activities are those at the level of a brisk walk. Vigorous-intensity activities increase your heart rate and breathing, and make you sweat. Examples include running, aerobic dance, and soccer.

How exercising lowers breast cancer risk is not fully understood. It's thought that physical activity regulates hormones including estrogen and insulin, which can fuel breast cancer growth.


Story Source:

The above story is based on materials provided by American Cancer Society. The original article was written by Stacy Simon. Note: Materials may be edited for content and length.


Journal Reference:

  1. Hildebrand JS, Gapstur SM, Campbell PT, Gaudet MM, Patel AV. Recreational physical activity and leisure-time sitting in relation to postmenopausal breast cancer risk. Cancer Epidemiology, Biomarkers, and Prevention, October 2013

Cite This Page:

American Cancer Society. "Study links moderate activity to lower breast cancer risk." ScienceDaily. ScienceDaily, 4 October 2013. <www.sciencedaily.com/releases/2013/10/131004090815.htm>.
American Cancer Society. (2013, October 4). Study links moderate activity to lower breast cancer risk. ScienceDaily. Retrieved July 22, 2014 from www.sciencedaily.com/releases/2013/10/131004090815.htm
American Cancer Society. "Study links moderate activity to lower breast cancer risk." ScienceDaily. www.sciencedaily.com/releases/2013/10/131004090815.htm (accessed July 22, 2014).

Share This




More Health & Medicine News

Tuesday, July 22, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Courts Conflicted Over Healthcare Law

Courts Conflicted Over Healthcare Law

AP (July 22, 2014) Two federal appeals courts issued conflicting rulings Tuesday on the legality of the federally-run healthcare exchange that operates in 36 states. (July 22) Video provided by AP
Powered by NewsLook.com
Why Do People Believe We Only Use 10 Percent Of Our Brains?

Why Do People Believe We Only Use 10 Percent Of Our Brains?

Newsy (July 22, 2014) The new sci-fi thriller "Lucy" is making people question whether we really use all our brainpower. But, as scientists have insisted for years, we do. Video provided by Newsy
Powered by NewsLook.com
Scientists Find New Way To Make Human Platelets

Scientists Find New Way To Make Human Platelets

Newsy (July 22, 2014) Boston scientists have discovered a new way to create fully functioning human platelets using a bioreactor and human stem cells. Video provided by Newsy
Powered by NewsLook.com
Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins